☆ 4.6 Editorial Material

Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm

BLOOD ADVANCES (2020)

Get Full Text
Add to Collection

Journal

BLOOD ADVANCES
Volume 4, Issue 16, Pages 4020-4027

Publisher

ELSEVIER
DOI: 10.1182/bloodadvances.2019000173

Keywords

-

Categories

Hematology

Funding

  1. MD Anderson Cancer Center (National Cancer Institute of the National Institutes of Health) [P30 CA016672]
  2. SagerStrong Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.